These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21425186)

  • 1. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Hao J; Campagnolo D; Liu R; Piao W; Shi S; Hu B; Xiang R; Zhou Q; Vollmer T; Van Kaer L; La Cava A; Shi FD
    Ann Neurol; 2011 Apr; 69(4):721-34. PubMed ID: 21425186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells.
    Martin JF; Perry JS; Jakhete NR; Wang X; Bielekova B
    J Immunol; 2010 Jul; 185(2):1311-20. PubMed ID: 20543101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation".
    Bielekova B; McFarland H
    Ann Neurol; 2012 Jan; 71(1):148-9. PubMed ID: 22275261
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
    Bielekova B; Catalfamo M; Reichert-Scrivner S; Packer A; Cerna M; Waldmann TA; McFarland H; Henkart PA; Martin R
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5941-6. PubMed ID: 16585503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
    Gan Y; Liu R; Wu W; Bomprezzi R; Shi FD
    J Neuroimmunol; 2012 Jun; 247(1-2):9-15. PubMed ID: 22503411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
    Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA
    Front Immunol; 2020; 11():714. PubMed ID: 32391016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose IL-2 induces CD56
    McQuaid SL; Loughran ST; Power PA; Maguire P; Szczygiel A; Johnson PA
    Clin Exp Immunol; 2020 Jun; 200(3):228-241. PubMed ID: 31989589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ozanimod-mediated remission in experimental autoimmune encephalomyelitis is associated with enhanced activity of CNS CD27
    Kamyan D; Hassane M; Alnaqbi A; Souid AK; Rasbi ZA; Tahrawi AA; Shamsi MA
    Front Immunol; 2024; 15():1230735. PubMed ID: 38533505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
    Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
    J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2.
    Leavenworth JW; Schellack C; Kim HJ; Lu L; Spee P; Cantor H
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2562-7. PubMed ID: 20133787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
    Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
    J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
    Blink SE; Caldis MW; Goings GE; Harp CT; Malissen B; Prinz I; Xu D; Miller SD
    Cell Immunol; 2014 Jul; 290(1):39-51. PubMed ID: 24860937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
    Ozdemir O; Ravindranath Y; Savaşan S
    J Immunother; 2005; 28(1):44-52. PubMed ID: 15614044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
    McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
    Front Immunol; 2021; 12():660506. PubMed ID: 34093549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.